ARTICLE | Clinical News
Periostat doxycycline: Phase III; marketed to treat periodontal disease
August 19, 2002 7:00 AM UTC
CGPI started a double-blind U.S. Phase III trial of its Periostat in up to 210 patients with rosacea, a chronic inflammatory disease characterized by redness of skin and lesions. ...